SOLICITATION NOTICE
99 -- Generation of transgenic mice for the Myosin 1c gene - RFQ
- Notice Date
- 8/24/2015
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 541711
— Research and Development in Biotechnology
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, Office of Research Facilities, 9000 Rockville Pike, Bldg. 13, Rm. 2E47, MSC 5738, Bethesda, Maryland, 20892-5738, United States
- ZIP Code
- 20892-5738
- Solicitation Number
- NIH-OLAO-OD3-RFQ3887032
- Archive Date
- 9/17/2015
- Point of Contact
- Shirlene M. Smith, Phone: 3014437979, Brendan Miller, Phone: 301-594-0957
- E-Mail Address
-
ssmith@od.nih.gov, Brendan.Miller2@nih.gov
(ssmith@od.nih.gov, Brendan.Miller2@nih.gov)
- Small Business Set-Aside
- Total Small Business
- Description
- Sow1 This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. The solicitation number for this requirement is NIH-OLAO-OD3-RFQ3887032 and this is a RFQ. The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2005-83. This acquisition will be processed as a fixed price requirement and is a small business set-aside. The North American Industry Classification System (NAICS) Code for this acquisition is 541711, and the small-business size standard is 500 employees. Award will be made on lowest price technically acceptable (LPTA). The National Institutes of Health is in need of a one year service contract for the generation of transgenic mice for the Myosin 1 c gene. The evaluation will be based on the demonstrated capabilities of the prospective Contractors in relation to the needs of the service as set forth in the RFQ. The merits of each proposal will be evaluated carefully. Each proposal must document the feasibility of successful implementation of requirement of the RFQ. Offerors must submit information sufficient to evaluate their proposals based on the detailed evaluation criteria. Please see the Statement of Work, Evaluation Criteria, and clauses for further information. The statement of work and evaluation criteria is in the attachment entitled "SOW-1". In order to be considered for an award, an offeror must have completed the online electronic Representations and Certifications located at https://www.sam.gov in accordance with FAR 4.1201(a). By submission of an offer, the offeror acknowledges the requirement that a prospective awardee shall be registered in SAM at https://www.sam.gov/ prior to award, during performance, and through final payment of any contract, basic agreement, basic ordering agreement, or blanket purchasing agreement resulting from this solicitation [Note: Lack of registration in the System for Award Management will make an offeror ineligible for award.] All responsible sources may submit an offer that will be considered by the Agency. Offers must be submitted no later than 10:00 A.M. Eastern Daylight Time on Thursday, September 2, 2015. Only E-mail submissions are accepted to ssmith@od.nih.gov by required response time. Fax submissions are not authorized. Requests for further information or questions concerning this requirement must be submitted in writing to ssmith@od.nih.gov no later than August 27, 2015.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/OLAO/NIH-OLAO-OD3-RFQ3887032/listing.html)
- Place of Performance
- Address: National Institute of Health/National Institute of Deafness and Other Communication Disorders, 35A Convent Drive, Building 35A, Room 3D908A, Bethesda, Maryland, 20892, United States
- Zip Code: 20892
- Zip Code: 20892
- Record
- SN03852326-W 20150826/150824235351-4094e32ce4b65fb5991c4f40595232e1 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |